First-in-Humans Application of 161Tb: A Feasibility Study Using 161Tb-DOTATOC

Volume: 62, Issue: 10, Pages: 1391 - 1397
Published: Feb 5, 2021
Abstract
161Tb has decay properties similar to those of 177Lu but, additionally, emits a substantial number of conversion and Auger electrons. The aim of this study was to apply 161Tb in a clinical setting and to investigate the feasibility of visualizing the physiologic and tumor biodistributions of 161Tb-DOTATOC. Methods:161Tb was shipped from Paul Scherrer Institute, Villigen-PSI, Switzerland, to Zentralklinik Bad Berka, Bad Berka, Germany, where it...
Paper Details
Title
First-in-Humans Application of 161Tb: A Feasibility Study Using 161Tb-DOTATOC
Published Date
Feb 5, 2021
Volume
62
Issue
10
Pages
1391 - 1397
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.